Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.20
Delayed Data
As of May 23
 +0.17 / +0.77%
Today’s Change
10.94
Today|||52-Week Range
24.43
+6.83%
Year-to-Date

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Valeant Pharmaceuticals International Inc have a median target of 17.50, with a high estimate of 35.00 and a low estimate of 8.75. The median estimate represents a -21.17% decrease from the last price of 22.20.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Hold stock in Valeant Pharmaceuticals International Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.76
Sales
$2.1B
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.96%
 
 
 
 
 
 
Growthannually -17.93%
 
 
 
 
 
 

Sales

Growthquarterly 2.97%
 
 
 
 
 
 
Growthannually -4.87%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.